POST Online Media Lite Edition


ChemoCentryx appoints Henry A. McKinnell, Jr. to board

Staff Writer |
Mountain View, Ca., USA - October 21, 2016, Mountain View, Ca., USA - ChemoCentryx, Inc. a clinical-stage biopharmaceutical company, announced that Henry A. McKinnell, Jr. has been appointed to the company's board of directors.

Article continues below

Dr. McKinnell brings significant leadership in operations, international alliances, and commercial experience to ChemoCentryx.

During more than thirty years in the pharmaceutical industry, Dr. McKinnell held a number of executive positions including Chairman and Chief Executive Officer of Pfizer Inc. from 2001 until his retirement in 2006.

Dr. McKinnell joined Pfizer in 1971 in Tokyo, and held positions of increasing responsibility around the world including president Asia, vice president strategic planning, chief financial officer and president and chief operating officer.

His recent honors include, among others, the Grand Cordon of the Order of the Rising Sun, Japan's highest award to those other than members of the Imperial Family and heads of state; the United Nations Association of the United States of America's Global Leadership Award; the Woodrow Wilson Institute Corporate Service Award; and Stanford University's Graduate School of Business Arbuckle Award and Excellence in Leadership Award.

Dr. McKinnell currently serves as Chairman of Moody's corporation. He also serves as a director of View Ray, Inc. and the Chairman Emeritus of the Connecticut Science Center.

He has served as a Director of the Trilateral Commission and the Business Council, and Chairman of the Stanford University Graduate School of Business Advisory Council, Chairman Emeritus of the Business-Higher Education Forum, a Fellow of the New York Academy of Medicine, and the Economic Club of New York.

He served as the Chairman of the Accordia Global Health Foundation and also served as a Senior Advisor to Toyota Motor Corporation's International Advisory Board and the Thomas H. Lee Private Equity Partnership.

Dr. McKinnell is the Chairman Emeritus of the Pharmaceutical Research and Manufacturers of America (PhRMA), the Food and Drug Law Institute and the Medical Device Manufacturers Association. He has served as a director of more than 12 public companies over twenty years.


What to read next

ViewRay appoints ex Pfizer CEO Henry McKinnell to board
ChemoCentryx appoints Geoffrey M. Parker to the board
Optimer Pharmaceuticals appoints board chairman as CEO